<DOC>
	<DOCNO>NCT02046187</DOCNO>
	<brief_summary>This study aim see reduce blood sugar increase ketone ( metabolic product come use fat energy ) increase survival enhance effect standard radiation chemotherapy treatment use treat glioblastoma multiforme ( GBM ) . These change occur use ketogenic diet . This research 2 goal : 1 . Show patient tolerate diet maintain low blood glucose high blood ketone level . 2 . Show diet enhances effectiveness standard treatment prolong survival patient GBM .</brief_summary>
	<brief_title>Ketogenic Diet With Radiation Chemotherapy Newly Diagnosed Glioblastoma</brief_title>
	<detailed_description>The investigator propose offer study patient newly diagnose glioblastoma multiforme ( GBM ) undergo gross total resection ( GTR ) subtotal resection ( STR ) tumor . Post-operatively , patient family instruct implementation Ketogenic Diet ( KD ) start soon possible follow surgery achieve ketosis reduction blood sugar . Patients receive standard chemoradiotherapy fractionate external beam radiation ( 60Gy ) concurrent oral temozolomide chemotherapy follow 12 adjuvant cycle temozolomide chemotherapy standard dose schedule . Outcome measure study group compare historic control treatment arm European Organization Research Treatment Cancer ( EORTC ) temozolomide study publish Roger Stupp et al , New England Journal Medicine , March 10 , 2005 . Note : Gross Total Resection ( GTR ) , Subtotal Resection ( STR ) , temozolomide ( Temodar ) , radiation therapy routine care GBM investigational component study . Study end-points : Primary : Ketogenic diet ( KD ) tolerance compliance brain tumor patient . The diet consider tolerable patient chooses remain compliant . Compliance monitor dietician use self reporting diet , blood glucose blood ketone level . Secondary : Overall survival , time recurrence , health therapy-related quality life . Overall survival progression free survival measure compare historic control receive chemoradiotherapy standard dose scheduling . Laboratory correlate : Molecular/immunohistochemical analysis tumor respond KD .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>adult patient , 18 80 year age , single enhance lesion brain MRI appearance consistent GBM Pathologic confirmation GBM Zubrod Performance Scale ( ZPS ) &lt; 2 Must able undergo MRI image gadolinium Must access computer internet ( use KetoCalculatorÂ© online Database ) unable undergo MRI gadolinium genetic disorder fat metabolism patient receive sodium valproate ( may cause false ketone read urine ) diabetes enrolled another treatment trial GBM</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Ketogenic Diet</keyword>
	<keyword>Brain tumor</keyword>
	<keyword>Glioma</keyword>
	<keyword>Glioblastoma</keyword>
	<keyword>Radiation</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>temozolomide</keyword>
</DOC>